“How Long Have I Got?” in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This Question
early symptoms of non small cell lung cancer :: Article Creator Non-Small Cell Lung Cancer Ryan Nguyen, DO, University of Illinois Chicago, highlights the importance of personalized care for patients who have non–small cell lung cancer (NSCLC) and the potential of artificial intelligence (AI) in oncology, while cautioning against its limitations, including the risk of unsupported recommendations. Non-small-cell Lung Cancer Articles From Across Nature Portfolio Developing multiple EGFR-mutant lung cancers The occurrence of multiple independent tumours in patients with EGFR-mutant lung cancer was unexplained. A recent study in Nature Cancer identified distinct genetic predisposition mechanisms, including developmental mosaicism and germline EGFR variants, that contribute to the formation of multiple primary tumours. How Accurate Is Liquid Biopsy In Diagnosing Lung Cancer? Many advancements have happened in the medical field that work toward...